Evaluation the Effect of TOPK Inhibitor in Lung Cancer Xenograft Model and Exploration the Function of TOPK via Gene Expression Profiling
碩士 === 輔仁大學 === 生命科學系碩士班 === 105 === Lung cancer ranks among the most deadly cancers worldwide. Despite the discovery of oncogenic driver mutation has leaded to develop novel molecular therapeutics, chemotherapy remains the mainstay of treatment for advanced patients without a known driver mutation....
Main Authors: | YANG, YUN-HSUAN, 楊允瑄 |
---|---|
Other Authors: | LAI, JIN-MEI |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/30587620908439455852 |
Similar Items
-
Identification and characterization of TOPK interaction protein by GST-TOPK pull down and LC/Mass/Mass analysis.
by: Mei-Chi Shih, et al.
Published: (2008) -
PBK/TOPK Expression Predicts Prognosis in Oral Cancer
by: Chin-Fang Chang, et al.
Published: (2016-06-01) -
Investigation the role of TOPK in cisplatin induced cytotoxicity of lung cancer cells
by: Chen,GuanJie, et al.
Published: (2013) -
PBK/TOPK: A Therapeutic Target Worthy of Attention
by: Ziping Han, et al.
Published: (2021-02-01) -
To evaluate the cytotoxic effect of TOPK inhibitor in combination with cisplatin in non-small cell lung cancer
by: Pyea-Yoo Kim, et al.
Published: (2015)